A Novel PGM3 Mutation Is Associated With a Severe Phenotype of Bone Marrow Failure, Severe Combined Immunodeficiency, Skeletal Dysplasia, and Congenital Malformations
Open Access
- 22 May 2017
- journal article
- case report
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 32 (9), 1853-1859
- https://doi.org/10.1002/jbmr.3173
Abstract
Congenital disorders of glycosylation (CDGs) affect multiple systems and present a broad spectrum of clinical features, often including skeletal dysplasia. Exome sequencing has led to the identification of new CDG genes. Immune and skeletal phenotypes associated with mutations in PGM3, encoding a protein that converts N‐acetyl‐glucosamine‐6‐phosphate into N‐acetyl‐glucosamine‐1‐phosphate, were recently reported. Through exome sequencing, we identified a novel homozygous mutation (c.1135T>C; p.Phe379Leu) in PGM3 in two siblings with bone marrow failure, severe combined immunodeficiency, renal and intestinal malformations, and a skeletal dysplasia resembling Desbuquois dysplasia. Severe respiratory compromise secondary to lung hypoplasia and pulmonary hypertension, and intestinal obstruction led to their demise. We thus report the most severe phenotype described so far associated with PGM3 mutations. This CDG should be considered in the presence of skeletal dysplasia associated with severe immunodeficiency. © 2017 American Society for Bone and Mineral Research.Keywords
This publication has 14 references indexed in Scilit:
- Susceptibility to infections, without concomitant hyper-IgE, reported in 1976, is caused by hypomorphic mutation in the phosphoglucomutase 3 ( PGM3 ) geneClinical Immunology, 2015
- Neonatal-onset T − B − NK + severe combined immunodeficiency and neutropenia caused by mutated phosphoglucomutase 3Journal of Allergy and Clinical Immunology, 2015
- Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009The New England Journal of Medicine, 2014
- PGM3 Mutations Cause a Congenital Disorder of Glycosylation with Severe Immunodeficiency and Skeletal DysplasiaAmerican Journal of Human Genetics, 2014
- Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levelsJournal of Allergy and Clinical Immunology, 2014
- Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairmentJournal of Allergy and Clinical Immunology, 2014
- Agm1/Pgm3-Mediated Sugar Nucleotide Synthesis Is Essential for Hematopoiesis and DevelopmentMolecular and Cellular Biology, 2007
- Familial immunodeficiency with cutaneous vasculitis, myoclonus, and cognitive impairmentAmerican Journal of Medical Genetics Part A, 2003
- Identification of human phosphoglucomutase 3 (PGM3) as N‐acetylglucosamine‐phosphate mutase (AGM1). PGM3 is equivalent to AGM1Annals of Human Genetics, 2002
- The Linkage Relationships of HL-A with other Genetic Marker SystemsHuman Heredity, 1975